U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Anti-thyroglobulin antibody positivity

MedGen UID:
1670955
Concept ID:
C4732836
Finding
Synonyms: Anti-thyroid globulin antibody positivity; TgAbs
 
HPO: HP:0032069

Definition

The presence of autoantibodies (immunoglobulins) in the serum that react to thyroglobulin. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAnti-thyroglobulin antibody positivity

Conditions with this feature

Familial hyperthyroidism due to mutations in TSH receptor
MedGen UID:
373154
Concept ID:
C1836706
Disease or Syndrome
A rare hyperthyroidism characterized by mild to severe hyperthyroidism, presence of goiter, absence of features of autoimmunity, frequent relapses while on treatment and a positive family history.
Thyroid hormone resistance, generalized, autosomal recessive
MedGen UID:
483749
Concept ID:
C3489796
Disease or Syndrome
A rare, autosomal recessive inherited disorder usually caused by mutations in the THRB gene. It is characterized by a defective physiological resistance to thyroid hormones, resulting in the elevation of thyroxin and triiodothyronine in the serum.
Immunodeficiency, common variable, 10
MedGen UID:
816321
Concept ID:
C3809991
Disease or Syndrome
Common variable immunodeficiency-10 (CVID10) is an autosomal dominant primary immunodeficiency characterized by childhood-onset of recurrent infections, hypogammaglobulinemia, and decreased numbers of memory and marginal zone B cells. Some patients may develop autoimmune features and have circulating autoantibodies. An unusual feature is central adrenal insufficiency (summary by Chen et al., 2013). For a general description and a discussion of genetic heterogeneity of common variable immunodeficiency, see CVID1 (607594).
Proteasome-associated autoinflammatory syndrome 2
MedGen UID:
1648482
Concept ID:
C4747989
Disease or Syndrome
Proteasome-associated autoinflammatory syndrome-2 (PRAAS2) is an autosomal dominant disorder with onset in early infancy. Affected individuals develop severe inflammatory neutrophilic dermatitis, autoimmunity, and variable immunodeficiency (summary by Poli et al., 2018). For a discussion of genetic heterogeneity of PRAAS, see PRAAS1 (256040).
Immunodeficiency 64
MedGen UID:
1684716
Concept ID:
C5231402
Disease or Syndrome
Immunodeficiency-64 with lymphoproliferation (IMD64) is an autosomal recessive primary immunodeficiency characterized by onset of recurrent bacterial, viral, and fungal infections in early childhood. Laboratory studies show variably decreased numbers of T cells, with lesser deficiencies of B and NK cells. There is impaired T-cell proliferation and activation; functional defects in B cells and NK cells may also be observed. Patients have increased susceptibility to EBV infection and may develop lymphoproliferation or EBV-associated lymphoma. Some patients may develop features of autoimmunity (summary by Salzer et al., 2016, Mao et al., 2018, and Winter et al., 2018).
Immunodeficiency 89 and autoimmunity
MedGen UID:
1794237
Concept ID:
C5562027
Disease or Syndrome
Immunodeficiency-89 and autoimmunity (IMD89) is an autosomal recessive immune disorder characterized by adult onset of recurrent infections, allergies, microcytic anemia, and Crohn disease (see 266600) (Yang et al., 2020).

Professional guidelines

PubMed

Wu L, Xu Y, Wang X, Cheng X, Zhang Y, Wang Y, Fan X, Zhao H, Liu H, Chai X, Zhang L, Wang M, Li N, Pan H, Lian X
Endocrine 2023 Jul;81(1):123-133. Epub 2023 Mar 3 doi: 10.1007/s12020-023-03323-9. PMID: 36867366

Recent clinical studies

Etiology

Wu L, Xu Y, Wang X, Cheng X, Zhang Y, Wang Y, Fan X, Zhao H, Liu H, Chai X, Zhang L, Wang M, Li N, Pan H, Lian X
Endocrine 2023 Jul;81(1):123-133. Epub 2023 Mar 3 doi: 10.1007/s12020-023-03323-9. PMID: 36867366
Li Y, Shan Z, Teng W
Eur J Endocrinol 2021 Dec 2;186(1):115-122. doi: 10.1530/EJE-21-0975. PMID: 34762596Free PMC Article
Yoon JH, Shin MH, Kim HN, Choi W, Park JY, Hong AR, Kim HK, Kang HC
Endocrinol Metab (Seoul) 2021 Jun;36(3):599-606. Epub 2021 Jun 2 doi: 10.3803/EnM.2021.965. PMID: 34074094Free PMC Article

Therapy

Wu L, Xu Y, Wang X, Cheng X, Zhang Y, Wang Y, Fan X, Zhao H, Liu H, Chai X, Zhang L, Wang M, Li N, Pan H, Lian X
Endocrine 2023 Jul;81(1):123-133. Epub 2023 Mar 3 doi: 10.1007/s12020-023-03323-9. PMID: 36867366
Li Y, Shan Z, Teng W
Eur J Endocrinol 2021 Dec 2;186(1):115-122. doi: 10.1530/EJE-21-0975. PMID: 34762596Free PMC Article

Prognosis

Yoon JH, Shin MH, Kim HN, Choi W, Park JY, Hong AR, Kim HK, Kang HC
Endocrinol Metab (Seoul) 2021 Jun;36(3):599-606. Epub 2021 Jun 2 doi: 10.3803/EnM.2021.965. PMID: 34074094Free PMC Article

Clinical prediction guides

Yoon JH, Shin MH, Kim HN, Choi W, Park JY, Hong AR, Kim HK, Kang HC
Endocrinol Metab (Seoul) 2021 Jun;36(3):599-606. Epub 2021 Jun 2 doi: 10.3803/EnM.2021.965. PMID: 34074094Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...